Precision therapy in pancreatic cancer: from streamlet towards mainstream
Pancreatic cancer is a highly dismal malignancy and has a poor response to major treatments. Patients with pancreatic cancer usually have poor prognosis. Precision therapy has a great potential to improve the outcome of pancreatic cancer. Over 25% of patients have druggable targets, which mainly inv...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Editorial Office of China Oncology
2022-11-01
|
| Edice: | Zhongguo aizheng zazhi |
| Témata: | |
| On-line přístup: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2022.10.004 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|